Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Messoud Ashina

Showing results (21-30 of 431) with videos related to

Pageof 44
Sort By:
Handbook of Clinical Neurology|September 7, 2010
Pharmacological migraine provocation: a human model of migraineMessoud Ashina, Jakob Møller Hansen
Cephalalgia : an International Journal of Headache|August 14, 2009
Extracranial source of increased CGRP in migraine children?Peer Tfelt-Hansen, Messoud Ashina
Ugeskrift for Laeger|April 10, 2008
[A new therapeutic principle for migraine]Messoud Ashina, Rigmor Højland Jensen
Headache|May 10, 2017
PACAP38: Emerging Drug Target in Migraine and Cluster HeadacheAnne Luise Haulund Vollesen, Messoud Ashina
The Journal of Headache and Pain|May 12, 2019
The changing faces of migrainePaolo Martelletti, Messoud Ashina, Lars Edvinsson
Cephalalgia : an International Journal of Headache|October 27, 2010
Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D₂ (PGD₂)Troels Wienecke, Jes Olesen, Messoud Ashina
Cephalalgia : an International Journal of Headache|December 3, 2013
Sphenopalatine ganglion neuromodulation in migraine: what is the rationale?Sabrina Khan, Jean Schoenen, Messoud Ashina
Cephalalgia : an International Journal of Headache|May 20, 2011
The L-kynurenine signalling pathway in trigeminal pain processing: a potential therapeutic target in migraine?Song Guo, L Vecsei, Messoud Ashina
The Journal of Headache and Pain|May 25, 2019
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)Paolo Martelletti, Lars Edvinsson, Messoud Ashina
Brain : a Journal of Neurology|August 28, 2014
Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increaseSong Guo, Jes Olesen, Messoud Ashina
Pageof 44

Showing results (21-30 of 431) with videos related to

Sort By:
Pageof 44
Handbook of Clinical Neurology|September 7, 2010
Pharmacological migraine provocation: a human model of migraineMessoud Ashina, Jakob Møller Hansen
Cephalalgia : an International Journal of Headache|August 14, 2009
Extracranial source of increased CGRP in migraine children?Peer Tfelt-Hansen, Messoud Ashina
Ugeskrift for Laeger|April 10, 2008
[A new therapeutic principle for migraine]Messoud Ashina, Rigmor Højland Jensen
Headache|May 10, 2017
PACAP38: Emerging Drug Target in Migraine and Cluster HeadacheAnne Luise Haulund Vollesen, Messoud Ashina
The Journal of Headache and Pain|May 12, 2019
The changing faces of migrainePaolo Martelletti, Messoud Ashina, Lars Edvinsson
Cephalalgia : an International Journal of Headache|October 27, 2010
Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D₂ (PGD₂)Troels Wienecke, Jes Olesen, Messoud Ashina
Cephalalgia : an International Journal of Headache|December 3, 2013
Sphenopalatine ganglion neuromodulation in migraine: what is the rationale?Sabrina Khan, Jean Schoenen, Messoud Ashina
Cephalalgia : an International Journal of Headache|May 20, 2011
The L-kynurenine signalling pathway in trigeminal pain processing: a potential therapeutic target in migraine?Song Guo, L Vecsei, Messoud Ashina
The Journal of Headache and Pain|May 25, 2019
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)Paolo Martelletti, Lars Edvinsson, Messoud Ashina
Brain : a Journal of Neurology|August 28, 2014
Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increaseSong Guo, Jes Olesen, Messoud Ashina
Pageof 44